# Sexually Transmitted Diseases Diagnostics Market and Forecast 2025-2033

Limited-Time Offer \[Flat 15% Discount\] [Dismiss](#)

[Skip to content](#content "Skip to content")

[Updated Data Matrix Available](https://www.ihealthcareanalyst.com/research-services/)

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals

[Home](https://www.ihealthcareanalyst.com/) » [Reports](https://www.ihealthcareanalyst.com/shop/) » [Clinical Diagnostics](https://www.ihealthcareanalyst.com/reports/clinical-diagnostics/amp/)

![Awaiting product image](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)

![Awaiting product image](https://www.ihealthcareanalyst.com/wp-content/uploads/2019/08/report-icon4-e1565791186498.png)

# Sexually Transmitted Diseases Diagnostics Market by Test Type (Chlamydia Testing, Gonorrhea Testing, P and S Syphillis Testing, HPV Testing, HSV Testing, HIV Testing, Chancroid Testing), Test Location (Laboratory Testing, POC Testing) and Forecast 2025-2033

$3,000.00

## Report Specifications: Market Size, Market Share, Growth Trends, Forecast, Geography

Sexually Transmitted Diseases (STDs) are caused by infections that are passed from one person to another during sexual contact. These infections often do not cause any symptoms. Medically, infections are only called diseases when they cause symptoms. The transmission can be averted by early identification or diagnosis of STDs and partner notification. Various tests are used for the identification and analysis of STDs.

Sexually transmitted diseases may result complications such as male and female infertility and other fatal complications or in morbidity in adult. STDs majorly affects population aged 15 – 44 years and results in ~500 million new infections or cases per year worldwide. Therefore, prevention and control of transmission of STDs is an imperative and the utmost priority across the globe.

The global sexually transmitted diseases diagnostics market report provides market size ($Million 2023 to 2033), market share, market trends and forecast (CAGR%, 2025 to 2033).

The global sexually transmitted diseases diagnostics market segmentation is based on test type (Chlamydia testing, Gonorrhea testing, P and S Syphillis testing, HPV testing, HSV testing, HIV testing, Chancroid testing), test location (laboratory testing, POC testing), and geography.

The global sexually transmitted diseases diagnostics market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

The global sexually transmitted diseases diagnostics market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global sexually transmitted diseases diagnostics market and included in this report are Abbott Laboratories, Inc. (Alere, Inc.), Becton Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux S.A., Danaher Corporation (Beckman Coulter/Cepheid), DiaSorin S.p.A., Hologic, Inc. (Gen-Probe, Inc.), OraSure Technologies, Inc., Qiagen NV, Roche Holdings AG (F. Hoffmann-La Roche AG), and Thermo Fisher Scientific, Inc.

**DATA INCLUDED:** Sexually Transmitted Diseases Diagnostics Market Size, Sexually Transmitted Diseases Diagnostics Market Share, Sexually Transmitted Diseases Diagnostics Market Growth Rates, Sexually Transmitted Diseases Diagnostics Market Trends, and Sexually Transmitted Diseases Diagnostics Market Forecast to 2033

**Market Data:**

*   Estimation Base Year: 2024
*   Historical Data Range: 2023-2024
*   Forecast Period: 2025-2033
*   Market Representation: Revenue in $million and CAGR % from 2025 to 2033
*   Regional Scope: North America, Europe, Asia Pacific, Latin America, Rest of the World (Middle East & Africa)
*   Country Scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Brazil, Mexico, South Africa, South Korea, Saudi Arabia, UAE, and other countries.
*   Report Coverage: Revenue forecasts, company market share, competitive landscape analysis, growth factors, and market trends
*   Customization Scope (15% Free): Accommodation of specific or custom requirements beyond the current report scope.

**Qualitative Analysis:**

*   Industry Overview
*   Industry Trends
*   Market Driver, Restraints, and Opportunities
*   Market Size
*   Growth Trends
*   Porter’s Five Forces Analysis
*   Market Attractiveness Matrix
*   Competitive Landscape
    *   Company Overview
    *   Financial Performance
    *   Product Portfolio
    *   Strategic Insights
    *   Recent Developments

**Quantitative Analysis:**

*   Market Size Projections: Comprehensive estimates and forecasts for all segments
*   Regional Market Analysis: Estimates and forecasts for key countries
*   Corporate Financial Performance: Analysis of company financials
*   Competitive Landscape: Market share analysis of leading companies

Choose License Type

Choose an optionSingle-user LicenseMulti-user LicenseCorporate License[Clear](#)

Sexually Transmitted Diseases Diagnostics Market by Test Type (Chlamydia Testing, Gonorrhea Testing, P and S Syphillis Testing, HPV Testing, HSV Testing, HIV Testing, Chancroid Testing), Test Location (Laboratory Testing, POC Testing) and Forecast 2025-2033 quantity 

Buy Report   

For inquiries regarding discounts on single or bundled report purchases, please reach out to us.

*   [Table of Contents CD](#tab-table-of-contents-cd)
*   [Market Segments and Companies](#tab-market-segments-and-companies)
*   [Request ToC / Sample](#tab-request-toc-sample-discount)

1.  **Introduction**
2.  **Executive Summary**
    *   Market Size Estimation ($million, 2023-2033)
    *   Forecast Estimation ($million and CAGR%, 2025-2033)
3.  [**Research Methodology**](https://www.ihealthcareanalyst.com/research-methodology/)
4.  **Market Landscape**
    *   Market Dynamics
        *   Drivers
        *   Barriers
        *   Opportunities
    *   Market Share Analysis
        *   Companies
        *   Products
    *   Market Trends Analysis
        *   Key success factors
        *   Market Growth Rate
    *   Market Attractiveness Analysis
    *   Market Profitability Analysis
        *   Buyer power
        *   Supplier power
        *   Barriers to entry
        *   Threat of substitute products
        *   Rivalry among firms in the industry
    *   Distribution Channels
5.  **Market Segmentation** \[_refer Market Segments and Companies Tab_\]
    *   Diagnostic Test Type
    *   Indication or Infection Type
    *   Technology
    *   Diagnostics Application
    *   Service Type
    *   End User Groups
6.  **Geography (Region, Country)**
    *   North America (U.S., Canada)
    *   Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    *   Asia Pacific (Japan, China, India, Rest of APAC)
    *   Latin America (Brazil, Mexico, Rest of LA)
    *   Rest of the World (Middle East & Africa)
7.  **Regulatory Overview** 
    *   Device Classification I, II, III, IV
    *   Device (FDA, EMEA) Approvals
8.  **Company Profiles** \[_refer Market Segments and Companies Tab_\]
    *   Company Overview
    *   Financial Snapshot
    *   Product Portfolio
    *   Business Strategies
    *   Recent Developments
9.  **Recommendations**
10.  **References**

**Key Questions Answered:**  
1\. What are the factors driving and limiting this market, key success factors and challenges?  
2\. Which are the leading competitors in the market, their market share, profitability and key trends by product, technology, services portfolio?  
3\. How do markets perform between countries and regions?  
4\. What market segments are contributing to maximum share and greatest growth?  
5\. What is the product or procedure volumes by country and regions?

**Actionable Insights Included:**  
1\. Product portfolio matrix (Share vs. Growth)  
2\. Market attractiveness (Region vs. Growth)  
3\. Spot matrix (Product vs. Region)  
4\. Geographic distribution matrix (Share vs. Growth)

**Sexually Transmitted Diseases Diagnostics Market**

1\. **Test Type**  
1.1 Chlamydia Test  
1.2 Gonorrhea Test  
1.3 P and S Syphillis Test  
1.4 HPV Test  
1.5 HSV Test  
1.6 HIV Test  
1.7 Chancroid Test

2\. **Location**  
2.1 Laboratory Testing  
2.2 Point-of-Care Testing

3\. **Geography (Region, Country)**  
3.1 North America (U.S., Canada)  
3.2 Latin America (Brazil, Mexico, Rest of LA)  
3.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)  
3.4 Asia Pacific (Japan, China, India, Rest of APAC)  
3.5 Rest of the World

4\. **Company Profiles**  
4.1. Abbott Laboratories, Inc. (Alere, Inc.)  
4.2. Becton Dickinson and Company  
4.3. Bio-Rad Laboratories, Inc.  
4.4. bioMerieux S.A.  
4.5. Danaher Corporation (Beckman Coulter/Cepheid)  
4.6. DiaSorin S.p.A.  
4.7. Hologic, Inc. (Gen-Probe, Inc.)  
4.8. OraSure Technologies, Inc.  
4.9. Qiagen NV  
4.10. Roche Holdings AG (F. Hoffmann-La Roche AG)  
4.11. Thermo Fisher Scientific, Inc.

**Request Table of Contents / Sample Report**

Full Name\*

Company Email\*

Phone Number\* \[Please add country code\]

Subject\*

Message\*

Resource Links

*   [About Us](https://www.ihealthcareanalyst.com/about/)
*   [Clinical Trials](https://www.ihealthcareanalyst.com/clinical-trials-dashboard/)
*   [Drugs@FDA](https://www.ihealthcareanalyst.com/drugs-fda-dashboard/)
*   [Orange Book](https://www.ihealthcareanalyst.com/orange-book-dashboard/)
*   [Premarket Approval](https://www.ihealthcareanalyst.com/premarket-approval-pma/)
*   [Premarket Notification](https://www.ihealthcareanalyst.com/premarket-notification-510k/)
*   [Publications](https://www.ihealthcareanalyst.com/publications/)

Terms and Conditions

*   [FAQs](https://www.ihealthcareanalyst.com/faqs/)
*   [Careers](https://www.ihealthcareanalyst.com/careers/)
*   [Terms of Use](https://www.ihealthcareanalyst.com/terms/)
*   [How to Order](https://www.ihealthcareanalyst.com/order/)
*   [Return Policy](https://www.ihealthcareanalyst.com/return/)
*   [Privacy Policy](https://www.ihealthcareanalyst.com/privacy/)
*   [Disclaimer Policy](https://www.ihealthcareanalyst.com/disclaimer/)

Secure Online Payment

![iHealthcareAnalyst, Inc.](https://www.ihealthcareanalyst.com/wp-content/uploads/2018/07/creditcard-payment-logos-300x48.jpg)

Search

Search

Contact Address

**US Office:** 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States  
Phone: +1 (314) 315-4764  
**India Office:** 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India  
Phone: +91 (20) 25898524  
Email: [\[email protected\]](/cdn-cgi/l/email-protection#1360727f7660537a7b76727f677b70726176727d727f6a60673d707c7e)

[](# "Scroll back to top")

Search for: